MedPath

Regenerative Therapy With Autologous Stromal Vascular Fraction Derived Mesenchymal Stem Cells and Platelet-rich Plasma to Treat Complex Perianal Diseases

Not yet recruiting
Conditions
Anal Fissure
Perianal Crohn Disease
Perianal Fistula
Rectovaginal Fistula
Perianal Fistula Due to Crohn's Disease
Registration Number
NCT05709717
Lead Sponsor
Kantonsspital Winterthur KSW
Brief Summary

Consecutive patients with complex anal fistula were prospectively followed for 12 months. Routine MRI was performed before and at 4 and 12 months after surgery. Continence was assessed likewise using a validated questionnaire. Fistula were drained with setons prior surgery. SVF was harvested from subcutaneous abdominal fat and PRP from peripheral blood. Distal fistulectomy to the sphincter was performed and the wound left open, while the internal orifice was closed. SVF-PRP was injected around the fistula. Patients showered their excision wound until dry. Outcomes were reported as median \& interquartile range (IQR)

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
50
Inclusion Criteria

Perianal fistula Perianal fissure Anovaginal fistula Rectovaginal fistula Perianal Crohn's disease

Exclusion Criteria

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Clinical Healing1 year

Absence of fistula opening and discharge, well-being

MRI healing1year

Absence of active fistula and abscess

Secondary Outcome Measures
NameTimeMethod
Fecal continence1 year

Vaizey score

Quality of life (general and related to perianal diseases)1 year

FIQoL

Costs1 year

Direct cost to patient, institution, and payee

Trial Locations

Locations (1)

Kantonsspital Winterthur

🇨🇭

Winterthur, Switzerland

© Copyright 2025. All Rights Reserved by MedPath